Skip to content

First-in-human Integrated Endoscopic Ultrasound (EUS) Navigation System Clinical Study

First-in-human Integrated Endoscopic Ultrasound (EUS) Navigation System Clinical Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06798545
Acronym
EZ-EUS1
Enrollment
64
Registered
2025-01-29
Start date
2025-01-28
Completion date
2026-03-31
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Diseases

Keywords

endoscopic ultrasound, EUS, navigation, pancreatic disease, training, education, learning curve

Brief summary

The complexity of the medical expertise required for endoscopic manipulation and image interpretation complicates the implementation of echo-endoscopy (or EUS for Endoscopic Ultrasound). The EZ-EUS system is designed to help the operator understand the orientation and the position of the probe tip in the patient. This system offers navigation similar to that of the Global Positioning System (GPS), but for EUS procedures. To achieve this, it uses a 3D model based on scanner imaging data recorded before the procedure. In this study, the intended purpose of the EZ-EUS system is to help echo-endoscopy operators to easily identify and assess the pancreatic gland, and to facilitate the detection of any lesions. The hypothesis is that, thanks to this tool, procedure times will be shortened, and the pancreas and its lesions will be fully imaged to facilitate their localization and characterization.

Detailed description

Since its inception in the 1980s, the field of endoscopic ultrasound (EUS) has experienced significant expansion and evolution and is now a pivotal component of pancreatobiliary assessment. Proficiency in EUS necessitates a synthesis of cognitive and technical competencies encompassing endoscopic manipulation, image interpretation, and an extensive comprehension of intraabdominal anatomical structures. Acquisition of these competencies is a progressive and highly operator-dependent process, and thereby necessitates an extended learning curve for practitioners. The American Society for Gastrointestinal Endoscopy (ASGE) has recommended the performance of a minimum of 190 supervised EUS for practicing autonomous EUS. However, the compliance of these parameters does not guarantee competence achievement, and there is a wide variability between endoscopists leading to disparities in the techniques' quality and irregular outcomes. The EZ-EUS system is designed to help the operator understand the orientation and the position of the probe tip in the patient. This system offers navigation similar to that of the Global Positioning System (GPS), but for EUS procedures. To achieve this, it uses a 3D model based on scanner imaging data recorded before the procedure. In this study, the intended purpose of the EZ-EUS system is to assist echo-endoscopy operators in accurately locating the pancreatic gland, conducting a comprehensive evaluation of the region of interest, and facilitating the detection and identification of lesions within it. We hypothesize that this tool will streamline procedure times and enable comprehensive imaging of the pancreas and its lesions, thereby reducing the need for expert guidance for trainees and shortening the EUS learning curve. This study is exploratory, prospective, monocentric and will compare two randomized groups (with and without the EZ-EUS navigation system).

Interventions

DEVICEendoscopic ultrasound with navigation system

Use of the EZ-EUS navigation system during the procedure

Sponsors

IRCAD
CollaboratorUNKNOWN
IHU Strasbourg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Man or woman over the age of 18 years old. * Patient having a EUS procedure for pancreas study planned within the frame of his or her clinical care. * Patient whom pre-operative imaging indicates one lesion, a suspicion of lesion, chronic pancreatitis or fatty pancreas. * Patient with a good definition on the CT scan done within the year to the EUS. * Patient able to receive and understand information related to the study and give his or her written consent. * Patient affiliated to the French social security system.

Exclusion criteria

* Patient with altered anatomy of the upper digestive tract due to previous surgery. * Patient with known abnormal anatomy of the upper digestive tract. * Patient wearing a pacemaker. * Patients with comorbidities that may increase the risk of perforation. * Patient presenting, according to the investigator's judgment, a disease which may prevent participation in the procedures provided for by the study. * Patient with an ASA \>3. Patient with ASA=3 must be validated by the Principal * Investigator (PI). * Patient unable to tolerate general anesthesia. * Patient with a body mass index (BMI) \< 18,5 and \> 40. * Patient with weight variations \>10% between the date on which the CT scan was performed and the date of the procedure. * Pregnant or lactating patient. * Patient in exclusion period (determined by a previous or a current study). * Patient under guardianship or trusteeship. * Patient under the protection of justice of deprives of liberty. * Patient in situation of emergency Perprocedure

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the EUS navigation system's procedure duration compared to standard procedure times1 dayComparison of the examination period duration between the two groups (experimental vs control)

Secondary

MeasureTime frameDescription
Assessment of the system's ease-of-use and technological maturity1 dayQualitative assessment of the system's ease-of-use and technological maturity using questionnaires. Appropriate statistical test will be used to compare each procedure. Results will be presented numerically and graphically.
Assessment of the EUS navigation system for reliability1 dayRate of device deficiencies during the procedure
Assessment of the EUS navigation system for patient safety1 monthRate of adverse events, adverse device effects and complications
Recording of procedure data for offline systeme performance assessment1 dayCollection and prospective review of EUS data, including video and electromagnetic coordinates provided by the sensor
Assessment of the registration method1 dayQuantitative (numerical) assessment of registration accuracy using Target Registration Error (TRE), defined as the distance between the predicted 3D location of an anatomical landmark by the navigation system and its true 3D location
Evaluation of the time required to perform individual step duration1 dayComparison of the duration of each individual step

Countries

France

Contacts

Primary ContactArmelle TAKEDA, PhD
armelle.takeda@ihu-strasbourg.eu+33390413608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026